Odyssey Therapeutics: Funding, Investors & Team (Sep 2026)
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines.
Odyssey Therapeutics has raised $725M across 5 funding rounds on record, the most recent an undisclosed round of $25.0M announced in May 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Odyssey Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Odyssey Therapeutics Funding Rounds
Odyssey Therapeutics raised $218M in a Series A announced in Dec 2021.
10 months later, a Series B of $168M was announced in Oct 2022.
1.2 years later, a Series C of $101M was announced in Dec 2023.
1.8 years later, a Series D of $213M was announced in Sep 2025.
8 months later, an undisclosed round of $25.0M was announced in May 2026.
Odyssey Therapeutics Founders and Leadership Team
Contact details for the Odyssey Therapeutics team: 3 of 4 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Odyssey Therapeutics Funding Compared to Other Biotechnology Startups
Odyssey Therapeutics' latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Odyssey Therapeutics in Biotechnology and Cambridge
Companies Similar to Odyssey Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Odyssey Therapeutics Funding FAQs
What does Odyssey Therapeutics do?
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines.
How much funding has Odyssey Therapeutics raised?
Odyssey Therapeutics has raised $725M across 5 rounds on record. The most recent is an undisclosed round of $25.0M announced in May 2026.
When did Odyssey Therapeutics last raise funding?
Odyssey Therapeutics' most recent funding round on record is an undisclosed round of $25.0M, announced in May 2026.
Who founded Odyssey Therapeutics?
FundedIQ lists David Pompliano (Founder), Gary D (Founder) at Odyssey Therapeutics.
Who is the CEO of Odyssey Therapeutics?
Gary Glick is listed as CEO at Odyssey Therapeutics.
Where is Odyssey Therapeutics headquartered?
Odyssey Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Odyssey Therapeutics have?
Odyssey Therapeutics is in the 51-100 employee band.
How does Odyssey Therapeutics' funding compare to other Biotechnology startups?
Odyssey Therapeutics' latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Odyssey Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Odyssey Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.